drugset / Trial / NCT07290400
Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension
RandomizedCrossoverOpen-labelTreatment
Summary
This is a Phase 2, open-label, randomized crossover study assessing the effect of moderate alcohol intake on the absorption and onset of action of Hezkue® sildenafil oral suspension in adult subjects. Participants will receive Hezkue® under different alcohol intake conditions in randomized sequence. Pharmacokinetic sampling and onset assessments will be performed after each administration, and safety will be monitored throughout the study.
Timeline
- Start
- 2026-04-15
- Primary completion
- 2026-06-15
- Completion
- 2026-06-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | — | Oral |